Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,948 | 37,790 | 48,642 | 47,159 | 61,325 |
| Marketable Securities | 292,583 | 426,541 | 335,459 | 428,041 | 68,321 |
| Receivables | N/A | N/A | 94 | 31 | 52 |
| TOTAL | $355,439 | $469,215 | $388,200 | $483,256 | $130,986 |
| Non-Current Assets | |||||
| PPE Net | 1,160 | 1,137 | 628 | 776 | 55 |
| Other Non-Current Assets | 608 | 1,134 | 76 | 72 | 71 |
| TOTAL | $1,768 | $2,271 | $703 | $847 | $126 |
| Total Assets | $357,207 | $471,487 | $388,904 | $484,104 | $131,112 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,961 | 6,174 | 3,755 | 1,633 | 2,053 |
| Accrued Expenses | 22,338 | 8,036 | 6,778 | 4,631 | 8,504 |
| TOTAL | $36,299 | $14,210 | $10,532 | $6,264 | $10,557 |
| Non-Current Liabilities | |||||
| TOTAL | $3,192 | $2,840 | $2,869 | $1,597 | $N/A |
| Total Liabilities | $39,492 | $17,050 | $13,401 | $7,861 | $10,557 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,117 | 54,680 | 43,410 | 43,213 | 34,928 |
| Common Shares | 6 | 6 | 4 | 4 | 3 |
| Retained earnings | -562,376 | -407,249 | -309,475 | -193,049 | -88,256 |
| Other shareholders' equity | -668 | -799 | -317 | -590 | -105 |
| TOTAL | $317,715 | $454,437 | $375,503 | $476,243 | $120,555 |
| Total Liabilities And Equity | $357,207 | $471,487 | $388,904 | $484,104 | $131,112 |